LG Display will shine a light on the role of displays in the post-COVID-19 contactless society at this year’s Consumer Electronics Show 2021, set to take place from Monday, the company said Thursday. The three key messages the company wants to convey this year are “Natural Reality,” “Lifestyle in Harmony” and “Better for People” -- with an overarching theme that displays brings the real world to those in front of them. LG Display’s display soluti

Industry Jan. 7, 2021

Samsung Display applied for a trademark for its Samsung OLED brand in 43 nations, in an attempt to stake out its leading position in the organic light-emitting diode market that is entering maturity. “The new brand logo serves to clearly present our brand identity and superior technology as a leading player in the OLED market as it shifts over to maturity,” said Baek Jee-ho, vice president of strategic marketing for small and medium displays at Samsung Display. “From hereon,

Industry Jan. 7, 2021

It may not be just an age-related lack of immunity that explains the higher death rates among senior citizens in the novel coronavirus pandemic. Some scholars are paying attention to the inverse correlation between the measles-mumps-rubella (MMR) vaccine coverage and COVID-19 fatality in their search for a possible deterrent against COVID-19 infection. Among them is Professor Kook Hoon of Chonnam National University Hospital’s pediatrics department. He says MMR vaccines could help mit

Industry Jan. 6, 2021

진행자: 임정요, Kevin Lee Selzer 1. Korea’s COVID-19 surge among fastest outside Europe [1] SEJONG -- South Korea has seen a 167.3 percent increase in the number of novel coronavirus infections over the past three months, higher than in major economies in South and Central America as well as in many other Asian nations. *infection: 감염 *major: 주요한 [2] The cumulative tally of COVID-19 cases to date in Korea came to 61,769 as of Jan. 1, compared with 23,106 on Sept. 21, 2020, according to ep

Podcast Jan. 6, 2021

If South Korea has not yet earned itself the moniker of the world’s biologics and vaccine factory, it appears committed to winning the title. As of Tuesday, rumors abound that the country’s Hanmi Pharmaceutical is being weighed as a potential contract manufacturer of the Moderna vaccine for COVID-19. Hanmi’s Plant No. 2 in Pyeongtaek, Gyeonggi Province, can put out an annual volume of 100 million doses of DNA vaccine and 1 billion doses of messenger RNA vaccine. The plant was

Industry Jan. 5, 2021

AstraZeneca’s COVID-19 vaccine (AZD1222) will be reviewed for potential approval in South Korea within the next 40 days, Korea’s Ministry of Food and Drug Safety announced Monday. According to the Drug Ministry, AstraZeneca Korea has submitted applications for approval for its vaccine to be manufactured locally under a contract with SK Bioscience and for more of the vaccine to be shipped from manufacturers in Italy, the US and the UK. AstraZeneca is required to submit further doc

Industry Jan. 4, 2021

Daewoong Pharmaceutical’s pancreatitis treatment Foistar (DWJ1248) is to enter a new phase 3 clinical trial in combination with Gilead Science’s remdesivir, the company said in a regulatory filing Monday. Foistar, which is administered orally in tablet form, uses camostat as its active ingredient and is hoped to reduce the viral load of COVID-19 in an infected person’s body. In the beginning of the race for COVID-19 treatments, scientists believed that repurposing drugs such

Industry Jan. 4, 2021

Displays that are interactive, transparent, bendable and emit sound are no longer the product of science fiction. In 2021, Korean display companies LG Display and Samsung Display are seeking to attract global clients with innovations in form factor and display performance, aiming to capitalize on the consumer electronics boom on the back of COVID-19.  One thing to note is the players, respectively known for their expertise in big displays and small displays -- LG for big organic light-em

Industry Jan. 3, 2021

We are what we buy. Our purchases reflect our needs and desires, formed by the circumstances and trends of the time. If before, people spent money on goods that would enhance their exteriors, such as garments and cosmetics, in pandemic-ridden 2020, confined to homes for the most part and always hidden behind masks when outdoors, many opted to buy items that would enrich their lives at home instead. In this listicle, we decided to pay tribute to the buys that made this weary year more bearable.

Industry Dec. 31, 2020

South Korea’s COVID-19 vaccine plans are slowly taking shape. Once shrouded in secrecy, the government is no longer holding back in sharing the outcomes of negotiations with individual vaccine firms in securing the doses necessary for the country. As of Wednesday, Korea has signed deals with AstraZeneca, Janssen and Pfizer-BioNTech, and is in close talks with Moderna, on top of the vaccines it is to receive through the global nonprofit COVAX facility. According to what is known through

Industry Dec. 30, 2020

Local biologics company Celltrion on Tuesday filed for approval of its COVID-19 antibody treatment for use here, in what Seoul officials hope will be a new weapon in the country’s war against the new coronavirus in the absence of vaccines. The Drug Ministry said it will attempt to review the safety and efficacy of the proposed COVID-19 treatment in the next 40 days. If approved, the drug is anticipated to be ready for use in February in Korea. Celltrion plans to submit similar applicati

Industry Dec. 29, 2020

Coronavirus variants spreading out of the UK and South Africa are new obstacles for companies struggling to bring forth viable treatments and vaccines for the COVID-19 pandemic. The outstanding question is: Are the treatments and vaccines thus far developed still effective against the coronavirus variants? According to the World Health Organization, the UK variant has a genetic mutation in the S gene, making its binding affinity to human receptor cells more powerful. Simply put, this makes th

Industry Dec. 27, 2020

Late on the front of coronavirus vaccine development and procurement, South Korea is pinning hopes on one particular company to provide the much-needed relief in this dark, pandemic winter -- Celltrion. The company is expected to announce in coming days results of its global clinical phase 2 trial of an anti-COVID-19 monoclonal antibody treatment candidate, CT-P59. Celltrion’s media-friendly founder and chairman Seo Jung-jin has said plenty of times that its drug, if approved, would &l

Industry Dec. 22, 2020

SK Innovation’s aggressive battery investments have trickle-down effects for local businesses in Korea and the US, the Korean firm claimed Friday, as it sought to burnish its contributions to the economy ahead of a lawsuit ruling in the US. The energy firm is currently building two electric battery plants in the US state of Georgia. The first of those, with capacity of 9.8 GWh of production a year, is expected to be finished and start test runs next year. It is due to enter full-fledged o

Industry Dec. 18, 2020

Lemonex, a South Korean biotherapeutics and biotech company, was acknowledged with an Industry and Energy Ministerial prize for technology innovation at the Innovation Winner 2020 awards. The Innovation Winner 2020 was hosted by Herald Corp. in collaboration with monthly magazine PowerKorea on Thursday. Lemonex won for its original drug delivery technology called DegradaBALL. “DegradaBALL enables effective delivery of various new drug candidates into cultured cells or lesions by loading

Industry Dec. 18, 2020